Abstract
Background Early detection of dementia is critical for intervention and care planning but remains difficult. Computerized cognitive testing provides an accessible and promising solution to address these current challenges. This study evaluated a computerized cognitive testing battery (BrainCheck) for its diagnostic accuracy and ability to distinguish the severity of cognitive impairment.
Methods 99 participants diagnosed with Dementia, Mild Cognitive Impairment (MCI), or Normal Cognition (NC) completed the BrainCheck battery. Statistical analyses compared participant performances on BrainCheck based on their diagnostic group.
Results BrainCheck battery performance showed significant differences between the NC, MCI, and Dementia groups, achieving ≥88% sensitivity/specificity for separating NC from Dementia, and ≥77% sensitivity/specificity in separating the MCI group from NC/Dementia groups. Three-group classification found true positive rates ≥80% for the NC and Dementia groups and ≥64% for the MCI group.
Conclusions BrainCheck was able to distinguish between diagnoses of Dementia, MCI, and NC, providing a potentially reliable tool for early detection of cognitive impairment.
Competing Interest Statement
The following authors declare the following competing interests: BH, KS, RHG, SY, HP, BK report personal fees from BrainCheck, outside the submitted work; BH, RHG reports receiving stock options from BrainCheck.
Funding Statement
Funding was provided by BrainCheck, Inc.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval was granted with the University of Washington Human Subjects Division under study ID: STUDY00000790 on August 1st, 2019.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data may be made available by contacting the corresponding author with a data use agreement.
https://depts.washington.edu/mbwc/adrc/page/research-resources
Abbreviations
- MCI
- Mild Cognitive Impairment
- NC
- Normal Cognition
- MoCA
- Montreal Cognitive Assessment
- SLUMS
- Saint Louis University Mental Status
- MMSE
- Mini-Mental State Examination
- NPT
- Neuropsychological Testing
- AD
- Alzheimer’s Disease
- ANOVA
- Analysis of Variance
- ROC
- Receiver Operating Characteristic
- AUC
- Area Under the Curve
- UW
- University of Washington
